Literature DB >> 31359523

Prospect of natural products in glioma: A novel avenue in glioma management.

Moumita Kundu1, Subhayan Das1, Dibakar Dhara2, Mahitosh Mandal1.   

Abstract

Glioma is one of the most perplexing cancers because of its infiltrating nature, molecular signaling, and location in central nervous system. Blood-brain barrier acts as a natural barrier to the glioma making it difficult to access by conventional chemotherapy. Clinicians are using natural compounds or their derivatives for several diseases including different cancers. However, the feasibility of using natural compounds in glioma is not explored in details. Natural compounds can act over a wide variety of signaling pathways such as survival and metabolic pathways and induce cell death. Some of the natural agents have additional benefits of crossing biological barriers such as blood-brain barrier with ease having few or no impact on the surrounding healthy cells. All of these benefits make natural compounds a prospective candidate for the glioma management. This article evaluates the benefits of using natural compounds for glioma therapy and their possible mechanism of actions. We have discussed the natural compounds assessed currently for glioma therapy and proposed a few novel natural compounds with potential antiglioma effect based on their mechanism of action.
© 2019 John Wiley & Sons, Ltd.

Entities:  

Keywords:  drug discovery; glioma; natural product; resistance; toxicity

Mesh:

Substances:

Year:  2019        PMID: 31359523     DOI: 10.1002/ptr.6426

Source DB:  PubMed          Journal:  Phytother Res        ISSN: 0951-418X            Impact factor:   5.878


  8 in total

Review 1.  Review on the Therapeutic Potential of Curcumin and its Derivatives on Glioma Biology.

Authors:  Malihe Mohamadian; Seyed Sajad Ahmadi; Afsane Bahrami; Gordon A Ferns
Journal:  Neurochem Res       Date:  2022-07-05       Impact factor: 4.414

2.  Mesenchymal stem cell-derived extracellular vesicles prevent glioma by blocking M2 polarization of macrophages through a miR-744-5p/TGFB1-dependent mechanism.

Authors:  Ling Liu; Meixiong Cheng; Tian Zhang; Yong Chen; Yaqiu Wu; Qi Wang
Journal:  Cell Biol Toxicol       Date:  2022-01-03       Impact factor: 6.819

3.  Glioma exosomal microRNA-148a-3p promotes tumor angiogenesis through activating the EGFR/MAPK signaling pathway via inhibiting ERRFI1.

Authors:  Meng Wang; Yi Zhao; Zhi-Yun Yu; Ren-De Zhang; Shu-Ang Li; Peng Zhang; Ti-Kun Shan; Xue-You Liu; Ze-Ming Wang; Pei-Chao Zhao; Hong-Wei Sun
Journal:  Cancer Cell Int       Date:  2020-10-27       Impact factor: 5.722

4.  Exploring the Activity of Fungal Phenalenone Derivatives as Potential CK2 Inhibitors Using Computational Methods.

Authors:  Sabrin R M Ibrahim; Alaa A Bagalagel; Reem M Diri; Ahmad O Noor; Hussain T Bakhsh; Yosra A Muhammad; Gamal A Mohamed; Abdelsattar M Omar
Journal:  J Fungi (Basel)       Date:  2022-04-24

5.  Identification of the potential biomarkers in patients with glioma: a weighted gene co-expression network analysis.

Authors:  Ting-Yu Chen; Yang Liu; Liang Chen; Jie Luo; Chao Zhang; Xian-Feng Shen
Journal:  Carcinogenesis       Date:  2020-07-10       Impact factor: 4.944

6.  SNHG1 Promotes Malignant Progression of Glioma by Targeting miR-140-5p and Regulating PI3K/AKT Pathway.

Authors:  Ren-Duan Cai; Chao-Cai Zhang; Li-Li Xie; Peng-Cheng Wang; Chui-Xue Huang; Jian-Long Chen; Hong-Tao Lv
Journal:  Cancer Manag Res       Date:  2020-11-24       Impact factor: 3.989

7.  Identification of autophagic target RAB13 with small-molecule inhibitor in low-grade glioma via integrated multi-omics approaches coupled with virtual screening of traditional Chinese medicine databases.

Authors:  Wei Su; Minru Liao; Huidan Tan; Yanmei Chen; Rongyan Zhao; Wenke Jin; Shiou Zhu; Yiwen Zhang; Li He; Bo Liu
Journal:  Cell Prolif       Date:  2021-10-10       Impact factor: 6.831

8.  Preliminary Study on the Therapeutic Effect of Doxorubicin-Loaded Targeting Nanoparticles on Glioma.

Authors:  Weitu Lan; Hongguang Zhang; Bo Yang
Journal:  Appl Bionics Biomech       Date:  2022-03-28       Impact factor: 1.781

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.